Cargando…
MicroRNA profile in very young women with breast cancer
BACKGROUND: Breast cancer is rarely diagnosed in very young women (35years old or younger), and it often presents with distinct clinical-pathological features related to a more aggressive phenotype and worse prognosis when diagnosed at this early age. A pending question is whether breast cancer in v...
Autores principales: | Peña-Chilet, Maria, Martínez, Maria T, Pérez-Fidalgo, Jose A, Peiró-Chova, Lorena, Oltra, Sara S, Tormo, Eduardo, Alonso-Yuste, Elisa, Martinez-Delgado, Beatriz, Eroles, Pilar, Climent, Joan, Burgués, Octavio, Ferrer-Lozano, Jaime, Bosch, Ana, Lluch, Ana, Ribas, Gloria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223555/ https://www.ncbi.nlm.nih.gov/pubmed/25047087 http://dx.doi.org/10.1186/1471-2407-14-529 |
Ejemplares similares
-
HDAC5 Inhibitors as a Potential Treatment in Breast Cancer Affecting Very Young Women
por: Oltra, Sara S., et al.
Publicado: (2020) -
miRNA Expression Analysis: Cell Lines HCC1500 and HCC1937 as Models for Breast Cancer in Young Women and the miR-23a as a Poor Prognostic Biomarker
por: Oltra, Sara S, et al.
Publicado: (2020) -
Acceleration in the DNA methylation age in breast cancer tumours from very young women
por: Oltra, Sara S., et al.
Publicado: (2019) -
Breast Cancer in Very Young Patients in a Spanish Cohort: Age as an
Independent Bad Prognostic Indicator
por: Martínez, María Teresa, et al.
Publicado: (2019) -
Methylation deregulation of miRNA promoters identifies miR124-2 as a survival biomarker in Breast Cancer in very young women
por: Oltra, Sara S., et al.
Publicado: (2018)